Singapore-Based A SPAC I Acquisition Prices US$60 Million IPO

Special purpose acquisition company A SPAC I Acquisition Corp. started trading on the Nasdaq Capital Market today. The firm aims to raise US$60.0 million in its initial public offering.

The offering consisted of 6.0 million company units at US$10.00 per unit. Each unit contains one Class A common share, three-fourths of a redeemable warrant, and one-tenth of a right. Each whole warrant is exercisable for one common share at US$11.50 per share while each whole right equates to one common share upon business combination. The shares, warrants, and rights, once trading separately, will be trading under “ASCA”, “ASCAW”, and “ASCAR”, respectively.

Chardan acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 0.9 million units at the same IPO price.

The offering is expected to close on February 17, 2022, subject to customary closing conditions.

The Singapore-based blank check firm intends to focus on completing a business combination in the technology, media, and telecom (TMT) sector.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

Capco Founder-Led SPAC Motive Capital II Prices Upsized US$300 Million IPO

Special purpose acquisition company Motive Capital Corp II (NYSE: MTVC.U) went public today on the...

Tuesday, December 7, 2021, 02:22:00 PM

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

Deep Tech Fund-Backed SPAC Ahren Acquisition Prices US$275 Million Upsized IPO

Special purpose acquisition company Ahren Acquisition Corp. (Nasdaq: AHRNU) started trading publicly on the Nasdaq...

Wednesday, December 15, 2021, 02:12:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq...

Tuesday, August 30, 2022, 02:19:00 PM